Standout Papers

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation 2009 2026 2014 2020 6.5k
  1. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)
    Manesh R. Patel, Kenneth W. Mahaffey et al. New England Journal of Medicine
  2. Low Diagnostic Yield of Elective Coronary Angiography (2010)
    Manesh R. Patel, Eric D. Peterson et al. New England Journal of Medicine
  3. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease (2015)
    Pamela S. Douglas, Udo Hoffmann et al. New England Journal of Medicine
  4. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance (2010)
    W. Gregory Hundley, David A. Bluemke et al. Circulation
  5. Detection of Myocardial Damage in Patients With Sarcoidosis (2009)
    Manesh R. Patel, Peter J. Cawley et al. Circulation
  6. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (2011)
    Keith A.A. Fox, Jonathan P. Piccini et al. European Heart Journal
  7. Relationship Between Infarct Size and Outcomes Following Primary PCI (2016)
    Gregg W. Stone, Harry P. Selker et al. Journal of the American College of Cardiology
  8. Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction (2014)
    Thomas M. Maddox, Maggie A. Stanislawski et al. JAMA
  9. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update (2012)
    Manesh R. Patel, Gregory Dehmer et al. Journal of the American College of Cardiology
  10. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease (2013)
    Michael J. Wolk, Steven R. Bailey et al. Journal of the American College of Cardiology
  11. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease (2016)
    William R. Hiatt, F. Gerry R. Fowkes et al. New England Journal of Medicine
  12. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease (2017)
    Manesh R. Patel, John Calhoon et al. Journal of the American College of Cardiology
  13. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes (2016)
    Manesh R. Patel, John Calhoon et al. Journal of the American College of Cardiology
  14. Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain (2018)
    Maros Ferencik, Thomas Mayrhofer et al. JAMA Cardiology
  15. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2014)
    Jonathan L. Halperin, Graeme J. Hankey et al. Circulation
  16. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials (2017)
    Suzanne de Waha, Manesh R. Patel et al. European Heart Journal
  17. Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain (2017)
    Udo Hoffmann, Maros Ferencik et al. Circulation

Immediate Impact

1 from Science/Nature 113 standout
Sub-graph 1 of 14

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
17 intermediate papers

Works of Manesh R. Patel being referenced

Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
2021
Effects of a 12-Week mHealth Program on FunctionalCapacity and Physical Activity in Patients With PeripheralArtery Disease
2018
and 17 more

Author Peers

Author Last Decade Papers Cites
Manesh R. Patel 21648 9010 8591 526 29.7k
Frans Van de Werf 30131 12126 9820 746 39.2k
Maarten L. Simoons 24442 10620 9291 351 31.8k
Debabrata Mukherjee 20481 11394 6419 447 28.9k
Joseph S. Alpert 36521 11541 11578 336 46.5k
Robert M. Califf 23485 7604 5901 305 29.7k
Kent R. Bailey 32444 8396 9085 580 43.0k
Stefan James 20923 11130 3982 483 25.8k
Cindy L. Grines 22487 17112 10413 489 30.9k
Christian W. Hamm 23067 12335 8151 838 32.2k
Marco Valgimigli 22770 14876 6839 516 28.7k

All Works

Loading papers...

Rankless by CCL
2026